MODERATOR
:
SPEAKER
(S):
Kathryn Bushnell, MT(ASCP), Technical Specialist, Dartmouth Hitchcock Medical Center
An Implementation Plan for ISBT Labeling of Cellular Therapy Products,,,
Leigh Poston, BS, MT(ASCP), Cytotherapy Laboratory Program Supervisor, University of Virginia Health System
Selecting ISBT Product Description Codes for Cellular Therapy Products- Is There an App for That?
Lizette Caballero, MLS (ASCP)CM, Senior Supervisor, UCSF BMT Laboratory
Implementing ISBT Labeling for Cellular Therapy Products: Avoid the Headaches
Description
The implementation of ISBT labeling for cellular therapy products presents unique challenges. This session will describe a practical approach to these challenges. Speakers will share a plan for implementation and discuss advantages and disadvantages to both free-standing and integrated systems. This session will also delve into the product description codes and the selection process of codes for manufactured products. Speakers from facilities that have already implemented ISBT labeling will discuss implementation development, challenges and lessons learned.
LEARNER OUTCOMES:
-
Develop a plan to implement International Society of Blood Transfusion (ISBT) labeling of cellular therapy products.
-
Discuss challenges and barriers to implementation and determine how to overcome them.
-
Identify the process steps that require labeling and select the appropriate product description codes for products manufactured.
-
Provide a guide for validation of the labeling process and qualification of the labeling material.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.